RFG
AZN icon

RFP Financial Group’s AstraZeneca AZN Stock Holding History

RFP Financial Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-253
Closed -$39.4K – 167
2024
Q2 		$39.4K Buy
253
+6
+2% +$903 0.01% 261
2024
Q1 		$33.4K Buy
247
+89
+56% +$11.8K 0.01% 257
2023
Q4 		$21.3K Buy
158
+87
+123% +$11.3K 0.01% 299
2023
Q3 		$9.52K Sell
71
-14
-16% -$1.91K ﹤0.01% 395
2023
Q2 		$14.6K Buy
85
+14
+20% +$2.06K 0.01% 361
2023
Q1 		$9.75K Sell
71
-14
-16% -$1.88K 0.01% 279
2022
Q4 		$12.8K Buy
+85
New +$10.7K 0.01% 356

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RFP Financial Group's AZN Position: Q3 2024 in Review

RFP Financial Group sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 253 shares — an estimated $39.4K sold.

RFP Financial Group first reported a position in AZN in Q4 2022 and held it in 7 quarters. The position peaked at $39.4K in Q2 2024. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • RFP Financial Group reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 253 AstraZeneca shares in Q3 2024, an estimated $39.4K.
  • RFP Financial Group first reported a position in AstraZeneca in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's AstraZeneca position peaked at $39.4K in Q2 2024.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.